AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 262: E383-E388, 1992;
0193-1849/92 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow A corrigendum has been published
Right arrow A corrigendum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Michel, M. C.
Right arrow Articles by Rascher, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Michel, M. C.
Right arrow Articles by Rascher, W.

AJP - Endocrinology and Metabolism, Vol 262, Issue 4 E383-E388, Copyright © 1992 by American Physiological Society

ARTICLES

NPY-stimulated Ca2+ mobilization in SK-N-MC cells is enhanced after isoproterenol treatment

M. C. Michel, F. Feth and W. Rascher
Department of Medicine, University of Essen, Federal Republic of Germany.

Neuropeptide Y (NPY) receptors in the SK-N-MC human neuroblastoma cell line couple to mobilization of intracellular Ca2+ and inhibition of adenylylcyclase. Pretreatment of SK-N-MC cells with isoproterenol enhanced the NPY-stimulated Ca2+ mobilization, mainly by increasing the maximal response to NPY. The enhancement was time-(maximal after 24 h) and concentration-dependent (maximal at 10 microM isoproterenol), blocked by the beta-adrenergic antagonist propranolol, and mimicked by forskolin. Concomitant treatment with cycloheximide prevented the enhancing effect of isoproterenol, suggesting the involvement of protein synthesis. Isoproterenol treatment did not alter the number or affinity of 125I-labeled NPY binding sites, the amount of pertussis toxin substrates, or NPY-mediated inhibition of cAMP accumulation. Similarly, isoproterenol treatment had no effect on basal intracellular Ca2+ and on Ca2+ increases elicited by carbachol, caffeine, or ionomycin. We conclude that isoproterenol treatment can sensitize NPY receptor responsiveness in a way that is specific for Ca2+ mobilization mechanisms used by this hormone.


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
V. Cortés, M.V. Donoso, N. Brown, R. Fanjul, C. López, A. Fournier, and J. P. Huidobro-Toro
Synergism between Neuropeptide Y and Norepinephrine Highlights Sympathetic Cotransmission: Studies in Rat Arterial Mesenteric Bed with Neuropeptide Y, Analogs, and BIBP 3226
J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1313 - 1322.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Cell Physiol.Home page
R. S. Mathias, K. Mikoshiba, T. Michikawa, A. Miyawaki, and H. E. Ives
IP3 receptor blockade fails to prevent intracellular Ca2+ release by ET-1 and alpha -thrombin
Am J Physiol Cell Physiol, June 1, 1998; 274(6): C1456 - C1465.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online